Literature DB >> 33422013

Swāsthya, an integrated chronic condition management programme for families of patients with hypertension and diabetes mellitus: a study protocol for a randomised controlled trial.

M D Saju1,2, Bindiya M Varghese3, Lorane Scaria4,5, Anuja Maria Benny4,5, Shilpa V Yohannan4,5, Natania Cheguvera4,5, S P Rajeev6, Amuthavalli Thiyagarajan Jotheeswaran7,8.   

Abstract

BACKGROUND: Kerala is known as the diabetes mellitus (DM) and hypertension (HTN) capital of the world, thus compelling health professionals to model strategies, addressing their social, behavioural, and cognitive risk factors and eliminating various barriers to management. This paper describes the protocol of our study that aims to examine the effectiveness and sustainability of an integrated care model for the management of chronic conditions and their risk factors through a family-based intervention. The proposed care model targets to modify systems and processes that predispose to chronic conditions by enhancing social cohesion and social networks, preventing lifestyle risks, developing iterative cognitive interventions, and engaging the family into customised treatment adherence strategies navigated by community health social workers (CHSWs).
METHODS: A cluster randomised controlled trial (RCT) in selected participants will be conducted involving additional assessments prior to the baseline assessment. The assessment will identify and categorise patients into four risk groups, namely behavioural, social, cognitive, and multiple, based on dominant risks identified. Eligible participants will be randomly allocated (at a ratio of 1:1) into the intervention or control arm. The intervention arm will receive social, behavioural, and cognitive or multiple interventions corresponding to the identified risk groups, whereas the control arm will receive general intervention. Both the groups will be followed up at 6 months and 12 months post baseline to measure outcomes. The primary outcome will be the control of HTN and DM, and secondary outcomes include decreased depression and anxiety and improved functioning, social cohesion, and social network linkages. The sustainability and scalability of this intervention will be assessed through cost effectiveness, acceptability, and user friendliness of the integrated approach by performing a qualitative evaluation. DISCUSSION: This RCT will inform the potential paradigm shift from a medical model of chronic condition management to a multidimensional, multisystem, and multidisciplinary convergence model navigated by CHSWs. Such a model is not currently considered in the management of chronic conditions in Kerala. TRIAL REGISTRATION: Trial has been prospectively registered on Clinical Trial Registry of India- CTRI/2020/12/029474 on 1st December 2020.

Entities:  

Keywords:  Diabetes mellitus; Hypertension; India; Integrated care model; Medical compliance; Study protocol

Year:  2021        PMID: 33422013      PMCID: PMC7797137          DOI: 10.1186/s12875-020-01357-w

Source DB:  PubMed          Journal:  BMC Fam Pract        ISSN: 1471-2296            Impact factor:   2.497


  14 in total

1.  Hypertension and lifestyle modification: how useful are the guidelines?

Authors:  Rachel Nicoll; Michael Y Henein
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

2.  India's escalating burden of non-communicable diseases.

Authors:  Perianayagam Arokiasamy
Journal:  Lancet Glob Health       Date:  2018-10-03       Impact factor: 26.763

Review 3.  Family-Based Approaches to Cardiovascular Health Promotion.

Authors:  Rajesh Vedanthan; Sameer Bansilal; Ana Victoria Soto; Jason C Kovacic; Jacqueline Latina; Risa Jaslow; Maribel Santana; Elio Gorga; Andrew Kasarskis; Roger Hajjar; Eric E Schadt; Johan L Björkegren; Zahi A Fayad; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

4.  Longitudinal effects of medication nonadherence on glycemic control.

Authors:  Leonard E Egede; Mulugeta Gebregziabher; Carrae Echols; Cheryl P Lynch
Journal:  Ann Pharmacother       Date:  2014-02-28       Impact factor: 3.154

5.  Measuring blood pressure knowledge and self-care behaviors of African Americans.

Authors:  Rosalind M Peters; Thomas N Templin
Journal:  Res Nurs Health       Date:  2008-12       Impact factor: 2.228

Review 6.  Comprehensive approach for hypertension control in low-income populations: rationale and study design for the hypertension control program in Argentina.

Authors:  Katherine T Mills; Adolfo Rubinstein; Vilma Irazola; Jing Chen; Andrea Beratarrechea; Rosana Poggio; Jacquelyn Dolan; Federico Augustovski; Lizheng Shi; Marie Krousel-Wood; Lydia A Bazzano; Jiang He
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

7.  The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Authors:  Craig J Currie; Mark Peyrot; Christopher Ll Morgan; Chris D Poole; Sara Jenkins-Jones; Richard R Rubin; Christopher M Burton; Marc Evans
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

8.  A PROgramme of Lifestyle Intervention in Families for Cardiovascular risk reduction (PROLIFIC Study): design and rationale of a family based randomized controlled trial in individuals with family history of premature coronary heart disease.

Authors:  Panniyammakal Jeemon; S Harikrishnan; G Sanjay; Sivasankaran Sivasubramonian; T R Lekha; Sandosh Padmanabhan; Nikhil Tandon; Dorairaj Prabhakaran
Journal:  BMC Public Health       Date:  2017-01-05       Impact factor: 3.295

9.  Social and behavioural risk factors in the prevention and management of cardiovascular disease in Kerala, India: a catchment area population survey.

Authors:  Saju Madavanakadu Devassy; Martin Webber; Lorane Scaria; Jotheeswaran Amuthavalli Thiyagarajan; Meredith Fendt-Newlin; Jacques Joubert; Anuja Maria Benny; Anjana Nannatt; Lynette Joubert
Journal:  BMC Cardiovasc Disord       Date:  2020-07-08       Impact factor: 2.298

10.  Socioeconomic status and risk factors for non-communicable diseases in low-income and lower-middle-income countries.

Authors:  Silvia Stringhini; Pascal Bovet
Journal:  Lancet Glob Health       Date:  2017-03       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.